Company news

Fulgent Genetics, Inc. news in 2024

Fulgent Genetics, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Fulgent Reports Third Quarter 2024 Financial Results

November 7, 2024

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans¹

October 30, 2024

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

October 16, 2024

Fulgent Reports Second Quarter 2024 Financial Results

August 1, 2024

Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024

July 10, 2024

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer

June 2, 2024

Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting

May 23, 2024

Fulgent Reports First Quarter 2024 Financial Results

May 2, 2024

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

April 10, 2024

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

February 27, 2024

Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024

February 12, 2024

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

February 8, 2024

Calls in 2024

Decks in 2024